Prime Capital Investment Advisors LLC cut its position in CME Group Inc. (NASDAQ:CME - Free Report) by 21.6% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,278 shares of the financial services provider's stock after selling 1,732 shares during the quarter. Prime Capital Investment Advisors LLC's holdings in CME Group were worth $1,730,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Heartland Bank & Trust Co acquired a new position in CME Group in the 1st quarter valued at $377,000. Catalyst Capital Advisors LLC raised its holdings in shares of CME Group by 256.9% during the 1st quarter. Catalyst Capital Advisors LLC now owns 3,662 shares of the financial services provider's stock worth $971,000 after buying an additional 2,636 shares in the last quarter. OMNI 360 Wealth Inc. acquired a new position in shares of CME Group during the 1st quarter worth $367,000. Fulcrum Equity Management acquired a new position in shares of CME Group during the 1st quarter worth $258,000. Finally, AIA Group Ltd raised its holdings in shares of CME Group by 17.8% during the 1st quarter. AIA Group Ltd now owns 16,645 shares of the financial services provider's stock worth $4,416,000 after buying an additional 2,510 shares in the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling
In related news, Director William R. Shepard purchased 262 shares of CME Group stock in a transaction on Thursday, September 25th. The shares were purchased at an average price of $265.19 per share, for a total transaction of $69,479.78. Following the transaction, the director owned 258,459 shares of the company's stock, valued at approximately $68,540,742.21. This represents a 0.10% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Timothy Francis Mccourt sold 379 shares of the company's stock in a transaction dated Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total value of $98,475.57. Following the completion of the sale, the insider owned 9,508 shares in the company, valued at $2,470,463.64. This trade represents a 3.83% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 13,043 shares of company stock worth $3,527,956. Corporate insiders own 0.30% of the company's stock.
CME Group Trading Up 0.5%
NASDAQ CME opened at $264.94 on Thursday. The business's 50-day moving average price is $269.26 and its two-hundred day moving average price is $271.06. CME Group Inc. has a 12 month low of $213.94 and a 12 month high of $290.79. The firm has a market capitalization of $95.48 billion, a PE ratio of 25.65, a price-to-earnings-growth ratio of 5.56 and a beta of 0.41. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12.
CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, beating analysts' consensus estimates of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The firm had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same quarter in the previous year, the company posted $2.56 EPS. The business's revenue was up 10.4% on a year-over-year basis. On average, analysts expect that CME Group Inc. will post 10.49 EPS for the current year.
CME Group Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th were given a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date was Tuesday, September 9th. CME Group's payout ratio is 48.40%.
Wall Street Analyst Weigh In
A number of research firms have recently commented on CME. Citigroup raised CME Group from a "neutral" rating to a "buy" rating and boosted their price target for the stock from $275.00 to $300.00 in a report on Thursday, September 25th. Wall Street Zen lowered CME Group from a "hold" rating to a "sell" rating in a research report on Sunday, July 13th. Oppenheimer boosted their price objective on CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a research report on Thursday, July 24th. JPMorgan Chase & Co. boosted their price objective on CME Group from $246.00 to $252.00 and gave the stock an "underweight" rating in a research report on Thursday, September 25th. Finally, Barclays reduced their price objective on CME Group from $298.00 to $280.00 and set an "equal weight" rating on the stock in a research report on Wednesday. Six analysts have rated the stock with a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $275.17.
View Our Latest Stock Report on CME
About CME Group
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.